Astrazeneca UK Ltd. v. Aurobindo Pharma Ltd.
413 F. App'x 288
Court of Appeals for the Federal Circuit·Decided March 24, 2011·No. Nos. 2010-1460, 2010-1461, 2010-1462, 2010-1463, 2010-1464, 2010-1465, 2010-1466, 2010-1467, 2010-1468, 2010-1469, 2010-1470, 2010-1471, 2010-1472, 2010-1473·Published·Cited by 1 cases
Opinion
MOTION
ORDER
Apotex Corp. moves for separate oral argument with respect to an issue in these appeals.
Upon consideration thereof,
It Is Ordered That:
The motion is deferred for consideration by the merits panel assigned to hear this case. Copies of this order, the motion and any response shall be transmitted to the merits panel.
Free access — add to your briefcase to read the full text and ask questions with AI
Astrazeneca UK Ltd. v. Aurobindo Pharma Ltd., 413 F. App'x 288 (Fed. Cir. 2011).
413 F. App'x 288 (Astrazeneca UK Ltd. v. Aurobindo Pharma Ltd.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.
Related
L'Oreal USA, Inc. v. Olaplex, Inc.
Federal Circuit, 2021